JP2015518005A5 - - Google Patents

Download PDF

Info

Publication number
JP2015518005A5
JP2015518005A5 JP2015509338A JP2015509338A JP2015518005A5 JP 2015518005 A5 JP2015518005 A5 JP 2015518005A5 JP 2015509338 A JP2015509338 A JP 2015509338A JP 2015509338 A JP2015509338 A JP 2015509338A JP 2015518005 A5 JP2015518005 A5 JP 2015518005A5
Authority
JP
Japan
Prior art keywords
composition
aqueous composition
capsule shell
weight
hpmcas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015509338A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015518005A (ja
JP6397813B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/055298 external-priority patent/WO2013164121A1/en
Publication of JP2015518005A publication Critical patent/JP2015518005A/ja
Publication of JP2015518005A5 publication Critical patent/JP2015518005A5/ja
Application granted granted Critical
Publication of JP6397813B2 publication Critical patent/JP6397813B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015509338A 2012-05-02 2013-03-14 ヒドロキシプロピルメチルセルロースアセテートスクシネート（ｈｐｍｃａｓ）の水性分散液 Expired - Fee Related JP6397813B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261641505P 2012-05-02 2012-05-02
US201261641485P 2012-05-02 2012-05-02
US61/641,505 2012-05-02
US61/641,485 2012-05-02
PCT/EP2013/055298 WO2013164121A1 (en) 2012-05-02 2013-03-14 Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas)

Publications (3)

Publication Number Publication Date
JP2015518005A JP2015518005A (ja) 2015-06-25
JP2015518005A5 true JP2015518005A5 (https=) 2018-05-17
JP6397813B2 JP6397813B2 (ja) 2018-09-26

Family

ID=47884337

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015509339A Expired - Fee Related JP6626712B2 (ja) 2012-05-02 2013-03-14 放出制御ポリマーの水性分散液並びにそのシェル及びカプセル
JP2015509338A Expired - Fee Related JP6397813B2 (ja) 2012-05-02 2013-03-14 ヒドロキシプロピルメチルセルロースアセテートスクシネート（ｈｐｍｃａｓ）の水性分散液
JP2017225773A Pending JP2018058870A (ja) 2012-05-02 2017-11-24 放出制御ポリマーの水性分散液並びにそのシェル及びカプセル

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015509339A Expired - Fee Related JP6626712B2 (ja) 2012-05-02 2013-03-14 放出制御ポリマーの水性分散液並びにそのシェル及びカプセル

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017225773A Pending JP2018058870A (ja) 2012-05-02 2017-11-24 放出制御ポリマーの水性分散液並びにそのシェル及びカプセル

Country Status (6)

Country Link
US (4) US10525010B2 (https=)
EP (4) EP2844296B1 (https=)
JP (3) JP6626712B2 (https=)
CA (2) CA2870134C (https=)
ES (2) ES2692644T3 (https=)
WO (2) WO2013164122A1 (https=)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2870134C (en) 2012-05-02 2020-04-28 Capsugel France SAS Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas)
KR102138545B1 (ko) 2012-08-24 2020-07-28 다우 글로벌 테크놀로지스 엘엘씨 고분자량 및 높은 균일성을 갖는 신규한 에스테르화된 셀룰로즈 에테르
US20160256399A1 (en) 2013-11-04 2016-09-08 Capsugel Belgium Nv Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
JP6254719B2 (ja) * 2014-04-08 2017-12-27 ダウ グローバル テクノロジーズ エルエルシー エステル化セルロースエーテルを含む分散体
ES2793530T3 (es) * 2014-05-19 2020-11-16 Tillotts Pharma Ag Cápsulas revestidas de liberación modificada
WO2015179072A1 (en) 2014-05-20 2015-11-26 Dow Global Technologies Llc Dispersion comprising a partially neutralized esterified cellulose ether
CN106456555B (zh) * 2014-05-20 2019-05-07 陶氏环球技术有限责任公司 包含酯化纤维素醚的胶囊壳
CN104055750B (zh) * 2014-07-03 2016-09-21 王荣辉 具有靶向功能的空心胶囊及制备方法
JP6722657B2 (ja) 2014-08-20 2020-07-15 スリーエム イノベイティブ プロパティズ カンパニー 試料の分割及び分析のためのデバイス及び方法
JP6865159B2 (ja) * 2014-08-20 2021-04-28 スリーエム イノベイティブ プロパティズ カンパニー 硫酸塩還元微生物用の内蔵型嫌気性培養デバイス
WO2016030234A1 (en) 2014-08-29 2016-03-03 Capsugel Belgium N.V. Colloidal dispersion comprising hpmcas
US10471152B2 (en) 2014-08-29 2019-11-12 Capsugel Belgium Nv Colloidal dispersion comprising HPMCAS
EP3236993B1 (en) 2014-12-23 2023-09-13 Theriva Biologics, Inc. Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
US10377835B2 (en) 2015-03-16 2019-08-13 Dow Global Technologies Llc Water-soluble esterified cellulose ethers
EP3270970B1 (en) 2015-03-16 2019-01-09 Dow Global Technologies LLC Gelling esterified cellulose ethers
MX2017011096A (es) 2015-03-16 2017-11-10 Dow Global Technologies Llc Solucion acuosa de un eter de celulosa esterificado.
US10214594B2 (en) 2015-03-16 2019-02-26 Dow Global Technologies Llc Water-soluble esterified cellulose ethers having a low degree of neutralization
US20160331689A1 (en) * 2015-05-12 2016-11-17 SE Tylose USA, Inc. Aqueous enteric coating composition
WO2017019276A1 (en) 2015-07-28 2017-02-02 Dow Global Technologies Llc Process for producing dispersion of esterified cellulose ether
WO2017048618A1 (en) 2015-09-16 2017-03-23 Dow Global Technologies Llc Water-redispersible polymer powder
WO2017052301A1 (ko) * 2015-09-25 2017-03-30 롯데정밀화학 주식회사 하이드로겔 시트용 조성물, 이로부터 제조되는 하이드로겔 시트 및 이의 제조 방법
CN108026184B (zh) * 2015-10-02 2020-09-15 陶氏环球技术有限责任公司 包含分散的酯化纤维素醚的水性组合物
KR102435660B1 (ko) * 2015-11-06 2022-08-24 롯데정밀화학 주식회사 건조 하이드로겔 시트의 제조방법 및 그 제조방법에 의해 제조된 건조 하이드로겔 시트
BR112018010354A2 (pt) * 2015-12-08 2018-12-04 Dow Global Technologies Llc composições compreendendo éteres de celulose e éteres de celulose esterificados solúveis em água
EP3199148B1 (en) * 2016-01-28 2020-12-02 Capsugel Belgium NV Compositions and resulting hard capsules comprising hydrophilic coloring foodstuff concentrates
WO2017146853A1 (en) * 2016-02-24 2017-08-31 Dow Global Technologies Llc Aqueous composition comprising water-soluble esterified cellulose ethers
PL239878B1 (pl) * 2016-03-30 2022-01-24 Gdanski Univ Medyczny Wodna kompozycja oraz sposób wytwarzania dojelitowych elastycznych filmów do sporządzania kapsułek z wodnej kompozycji oraz dojelitowy elastyczny film do sporządzania kapsułek miękkich
JP6683561B2 (ja) 2016-07-12 2020-04-22 信越化学工業株式会社 腸溶性硬カプセル用組成物及び腸溶性硬カプセルの製造方法
EP3272340A1 (en) * 2016-07-22 2018-01-24 Capsugel Belgium NV Acid resistant capsules
KR20180062784A (ko) * 2016-12-01 2018-06-11 롯데정밀화학 주식회사 경질캡슐의 제조방법 및 이로부터 제조되는 경질캡슐
WO2018175648A1 (en) * 2017-03-21 2018-09-27 Bioduro, Llc Gastrointestinal-protective formulations for oral delivery of proteins and peptides
JP7198205B2 (ja) 2017-07-11 2022-12-28 クオリカプス株式会社 腸溶性硬質カプセル
CO2017007322A1 (es) * 2017-07-24 2019-01-31 Novamed S A Cápsulas duras resistentes al ácido con bajo contenido de coadyuvantes de gelificacion
WO2019032573A1 (en) 2017-08-07 2019-02-14 Finch Therapeutics, Inc. COMPOSITIONS AND METHODS FOR MAINTAINING AND RESTORING A HEALTHY INTESTINAL BARRIER
CA3087569A1 (en) 2018-01-09 2019-07-18 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
KR102086461B1 (ko) * 2018-01-19 2020-03-09 주식회사 서흥 열겔화 히프로멜로오스 하드 캡슐의 제조방법
BR112020017090A8 (pt) 2018-02-23 2022-07-05 Crestovo Holdings Llc Imunoterapias relacionadas com microbioma
US11980691B2 (en) 2018-03-15 2024-05-14 R.P. Scherer Technologies, Llc Enteric softgel capsules
WO2019183208A1 (en) 2018-03-20 2019-09-26 Synthetic Biologics, Inc. Intestinal alkaline phosphatase formulations
EP4275761A3 (en) 2018-03-20 2024-02-28 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
ES2895161T3 (es) 2018-05-14 2022-02-17 Capsugel Belgium Nv Cápsulas con opacificante
BR112020026058A2 (pt) 2018-06-22 2021-04-13 Qualicaps Co., Ltd. Cápsula entérica dura
EP3829644A4 (en) * 2018-07-30 2022-05-04 Ricoh Company, Ltd. PROCESS FOR MANUFACTURING PARTICLES AND PARTICLE AND MEDICATION MANUFACTURED BY THE PROCESS
JP7503781B2 (ja) * 2018-07-30 2024-06-21 株式会社リコー 粒子の製造方法、並びに、それにより製造された粒子及び医薬
WO2020131801A1 (en) 2018-12-18 2020-06-25 DDP Specialty Electronic Materials US, Inc. A sustained release composition comprising a hydroxypropyl methylcellulose acetate succinate
EP3937909B1 (en) 2019-03-14 2026-03-04 Evonik Operations GmbH Capsule shell comprising a core-shell polymer and a cellulose
BR112021022194A2 (pt) 2019-05-07 2021-12-28 Bausch Health Ireland Ltd Formulações líquidas para dosagem oral de metilnaltrexona
CA3146738A1 (en) 2019-07-18 2021-01-21 Synthetic Biologics, Inc. Intestinal alkaline phosphatase-based treatments of metabolic disorders
US12290538B2 (en) 2019-07-19 2025-05-06 Finch Therapeutics Holdings Llc Methods and products for treatment of gastrointestinal disorders
CN110507629B (zh) * 2019-09-02 2021-02-23 广东广发制药有限公司 一种植物纤维素软胶囊胶皮及其制备方法
CN114650833A (zh) 2019-09-13 2022-06-21 芬奇治疗控股有限责任公司 用于治疗孤独症谱群障碍的组合物和方法
CA3153328A1 (en) * 2019-10-16 2021-04-22 Aouatef Bellamine Method and composition for increasing muscle protein synthesis
AU2020366529A1 (en) 2019-10-18 2022-05-19 Finch Therapeutics Holdings Llc Compositions and methods for delivering a bacterial metabolite to a subject
WO2021097288A1 (en) 2019-11-15 2021-05-20 Finch Therapeutics Holdings Llc Compositions and methods for treating neurodegenerative diseases
US12552951B2 (en) * 2019-12-17 2026-02-17 Agfa Nv Aqueous dispersion of polymeric capsules
WO2021142358A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatic encephalopathy (he)
WO2021142347A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for non-alcoholic steatohepatitis (nash)
TW202140049A (zh) 2020-01-10 2021-11-01 美商芬奇治療控股有限責任公司 用於治療ｂ型肝炎（ｈｂｖ）及ｄ型肝炎（ｈｄｖ）之組合物及方法
WO2021202806A1 (en) 2020-03-31 2021-10-07 Finch Therapeutics Holdings Llc Compositions comprising non-viable fecal microbiota and methods of use thereof
CA3177250A1 (en) 2020-05-02 2021-11-11 Bausch Health Ireland Limited Methods of reducing mortality risk in subjects suffering from an underlying disease or condition by administration of methylnaltrexone
JP2023553309A (ja) * 2020-11-25 2023-12-21 キャプシュゲル・ベルジウム・エヌ・ヴィ 二重層遅延放出硬質カプセル
WO2022115681A2 (en) * 2020-11-30 2022-06-02 Romeg Therapeutics Llc Methods and compositions for oral pilocarpine liquid
US20240263251A1 (en) 2021-02-19 2024-08-08 Finch Therapeutics Holdings Llc Compositions and methods for providing secondary bile acids to a subject
JP7833456B2 (ja) * 2021-05-18 2026-03-19 キャプシュゲル・ベルジウム・エヌ・ヴィ 非ゼラチン硬カプセル及びその製造方法
JP2025519816A (ja) 2022-06-21 2025-06-26 ニュートリション アンド バイオサイエンシズ ユーエスエー １，リミティド ライアビリティ カンパニー 硬質シェルカプセル、フィルム及びコーティングのためのフィルム形成遅延／腸溶配合物

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US338818A (en) * 1886-03-30 Picket-fence
GB643853A (en) 1946-04-13 1950-09-27 Lilly Co Eli Medicinal capsules and process of manufacture
US2718667A (en) 1952-05-01 1955-09-27 Eastman Kodak Co Method of preparing enteric capsules
GB1144225A (en) 1965-09-07 1969-03-05 Dow Chemical Co Preparation of medicinal capsule shells from hydroxyalkyl-alkyl cellulose ethers
US3740421A (en) 1966-09-19 1973-06-19 Basf Wyandotte Corp Polyoxyethylene-polyoxypropylene aqueous gels
US3617588A (en) 1969-06-16 1971-11-02 Dow Chemical Co Dip-coating process for preparing cellulose ether capsule shells
CA944689A (en) * 1970-07-28 1974-04-02 Claude Rene Capsules en matieres plastiques et leurs procedes de fabrication
US4001211A (en) 1974-12-02 1977-01-04 The Dow Chemical Company Pharmaceutical capsules from improved thermogelling methyl cellulose ethers
US4138013A (en) 1976-08-27 1979-02-06 Parke, Davis & Company Enteric capsules
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
JPH027925B2 (https=) 1978-10-02 1990-02-21 Purdue Research Foundation
JPS5890428A (ja) 1981-11-17 1983-05-30 Hitachi Denshi Ltd 自動組立装置
JPS58138458A (ja) 1982-02-10 1983-08-17 信越化学工業株式会社 腸溶性カプセルの製造方法
DE3222476A1 (de) 1982-06-15 1983-12-15 Warner-Lambert Co., 07950 Morris Plains, N.J. Magensaftresistente weichgelatinekapseln und verfahren zu ihrer herstellung
US4656066A (en) 1982-12-20 1987-04-07 Warner-Lambert Company Apparatus and method for sealing capsules
US4539060A (en) 1983-02-18 1985-09-03 Warner-Lambert Company Apparatus and method of sealing capsules
JPS6114584U (ja) 1984-06-28 1986-01-28 株式会社 宮川製作所 電話回線ル−プ電流瞬断防止装置
JPS62104593A (ja) 1985-10-31 1987-05-15 Terumo Corp アミノ酸脱炭酸能検査用培地組成物
EP0352800A3 (en) * 1988-07-28 1991-05-08 Warner-Lambert Company Aqueous polymeric dispersion of cellulosic and acrylic based polymers for preparing pharmaceutical dosage forms and dosage forms thereof
JPH0347246A (ja) 1989-04-13 1991-02-28 Olympus Optical Co Ltd 内視鏡用処置具
JPH0634807B2 (ja) 1989-06-08 1994-05-11 信越化学工業株式会社 医薬用硬質カプセルの製造方法
JP2552937B2 (ja) 1990-03-29 1996-11-13 日本エランコ株式会社 医薬用硬質カプセルおよびその製造方法
US5264223A (en) 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5273760A (en) * 1991-12-24 1993-12-28 Euroceltigue, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
JP3839467B2 (ja) 1992-06-04 2006-11-01 スミスクライン・ビーチャム・コーポレイション 味の良い医薬組成物
JP3017906B2 (ja) * 1993-10-08 2000-03-13 信越化学工業株式会社 腸溶性コーティング剤分散液
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
US5756123A (en) 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
AU4367396A (en) * 1994-12-05 1996-06-26 Permethyl Specialties L.L.C. Water soluble, biodegradable polymeric materials for skin care, hair care and cosmetic applications
US5851579A (en) * 1996-10-28 1998-12-22 Eastman Chemical Company Aqueous enteric coating compositions
US5910319A (en) * 1997-05-29 1999-06-08 Eli Lilly And Company Fluoxetine enteric pellets and methods for their preparation and use
JP5068401B2 (ja) 1998-09-28 2012-11-07 カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップ Ｈｐｍｃカプセルを使用する腸及び結腸への送達
DE19901686A1 (de) 1999-01-18 2000-07-20 Gruenenthal Gmbh Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung
US6515008B1 (en) * 2000-05-04 2003-02-04 Smithkline Beecham Corporation Formulation
SE0100200D0 (sv) * 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
EP1262174A1 (en) 2001-06-01 2002-12-04 Celanese Ventures GmbH Two part hard shell capsule made of poly(1,4-alpha-D-glucane) and starch
KR100461566B1 (ko) 2001-11-15 2004-12-14 삼성정밀화학 주식회사 수계 분산 히드록시프로필메틸 셀룰로오스 프탈레이트나노입자의 제조방법
KR20100047349A (ko) 2001-11-22 2010-05-07 모리시타 진탄 가부시키가이샤 비젤라틴계 캡슐 피막 조성물 및 이를 이용한 캡슐
FR2829142B1 (fr) * 2001-12-27 2004-02-13 Ulice Composition filmogene d'heteroxylanes pour la fabrication de capsules ainsi obtenues
AU2003274683A1 (en) 2002-08-02 2004-02-23 Scitech Centre NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS.
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
ES2500316T3 (es) 2002-10-01 2014-09-30 Banner Pharmacaps, Inc. Composición entérica para la fabricación de una cubierta de cápsula blanda
KR100483072B1 (ko) 2003-11-26 2005-04-14 박현진 하드 캅셀에 적합한 필름 형성 조성물 및 이의 제조방법
TW200520790A (en) 2003-12-22 2005-07-01 Dah Feng Capsule Industry Co Ltd The compositions of a vegetarian capsule shell
US20070298095A1 (en) * 2004-05-24 2007-12-27 Shionogi Qualicaps Co., Ltd. Surface-Modified and Solubility-Improved Hard Capsule
JP2006016372A (ja) 2004-07-05 2006-01-19 Shionogi Qualicaps Co Ltd 腸溶性硬カプセル剤
WO2006082842A1 (ja) 2005-02-03 2006-08-10 Qualicaps Co., Ltd. 溶解性が改善された硬カプセル
WO2006132398A1 (ja) 2005-06-06 2006-12-14 Ajinomoto Co., Inc. カプセル皮膜用組成物
US20070053869A1 (en) * 2005-09-02 2007-03-08 Yuichi Sugiyama Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents
US20070082046A1 (en) * 2005-10-11 2007-04-12 Banner Pharmacaps, Inc. Enteric valproic acid
CN102488652B (zh) * 2006-03-16 2014-06-18 特瑞斯制药股份有限公司 含有药物-离子交换树脂复合物的经修饰释放的制剂
ES2360423T3 (es) 2006-04-26 2011-06-03 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal.
DE602007008470D1 (en) * 2006-10-17 2010-09-23 Bend Res Inc Off
KR20120038021A (ko) * 2006-10-27 2012-04-20 화이자 프로덕츠 인코포레이티드 하이드록시프로필 메틸 셀룰로스 경질 캡슐 및 이의 제조 방법
GB0706178D0 (en) 2007-03-29 2007-05-09 Univ Aston Enteric pharmaceutical capsules
US8105625B2 (en) 2007-04-05 2012-01-31 University Of Kansas Rapidly dissolving pharmaceutical compositions comprising pullulan
JP5632282B2 (ja) * 2007-08-02 2014-11-26 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ Ｎ，ｎ−ジエチルアミノエチルメタクリラートをベースとする水性ポリマーディスパージョン、その調製及び使用
US20090074944A1 (en) * 2007-09-18 2009-03-19 Viva Pharmaceuticals Inc. Enteric coatings for orally ingestible compositions
JP5667874B2 (ja) 2007-10-19 2015-02-12 ファイザー・プロダクツ・インク マルチコンパートメント容器
WO2009063916A1 (ja) * 2007-11-16 2009-05-22 Asahi Kasei Chemicals Corporation 水系フィルムコーティング液、および、フィルムコーティング顆粒、ならびに、これを用いた錠剤
KR101235951B1 (ko) 2008-05-12 2013-02-21 화이자 인코포레이티드 통기구를 구비한 개선된 캡슐
US20100158997A1 (en) 2008-12-18 2010-06-24 Liang Chang Dong Blow-molded thin-walled drug delivery capsules
US9107451B2 (en) 2009-07-29 2015-08-18 Evonik Röhm Gmbh Coating composition for the dip coating of capsule halves
KR101705204B1 (ko) * 2009-09-11 2017-02-09 롯데정밀화학 주식회사 장용성 경질 캡슐용 수성 조성물, 장용성 경질 캡슐의 제조방법 및 장용성 경질 캡슐
DK2480218T3 (da) 2009-09-24 2020-08-24 Capsugel Belgium Nv Syreresistente kapsler
KR101182827B1 (ko) 2010-06-11 2012-09-14 삼성정밀화학 주식회사 장용성 경질 캡슐의 제조방법 및 장용성 경질 캡슐
KR101787481B1 (ko) 2010-10-21 2017-10-18 롯데정밀화학 주식회사 장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐
EP2722104B1 (en) * 2010-10-26 2018-03-07 Capsugel Belgium NV Bulk Enteric Capsule Shells
EP2726053B1 (en) * 2011-09-29 2018-10-24 Union Carbide Chemicals & Plastics Technology LLC Cationic conditioner replacements
WO2013150331A1 (en) * 2011-11-09 2013-10-10 Capsugel Belgium Nv Acid resistant banding solution for acid resistant two piece hard capsules
CA2870134C (en) 2012-05-02 2020-04-28 Capsugel France SAS Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas)
WO2015179072A1 (en) 2014-05-20 2015-11-26 Dow Global Technologies Llc Dispersion comprising a partially neutralized esterified cellulose ether
US10471152B2 (en) 2014-08-29 2019-11-12 Capsugel Belgium Nv Colloidal dispersion comprising HPMCAS
TWI587880B (zh) 2015-03-24 2017-06-21 Can be made into the composition of enteric capsule shell, enteric capsule shell and its process
US9452141B1 (en) 2015-05-01 2016-09-27 Dah Feng Capsule Industry Co., Ltd. Acid resistant capsule shell composition, acid resistant capsule shell and its preparing process
EP3566699A1 (en) * 2015-11-10 2019-11-13 Capsugel Belgium NV Acid resistant banding or sealing solution for acid resistant two piece hard capsules
US20170157058A1 (en) 2015-12-08 2017-06-08 Dah Feng Capsule Industry Co., Ltd. Acid resistant capsule shell composition, acid resistant capsule shell and its preparing process
EP3272340A1 (en) 2016-07-22 2018-01-24 Capsugel Belgium NV Acid resistant capsules

Similar Documents

Publication Publication Date Title
JP2015518005A5 (https=)
WO2013164121A4 (en) Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas)
TWI472323B (zh) 用於腸溶性硬膠囊的水性組合物、腸溶性硬膠囊的製備方法以及以後者方法製備而得的硬膠囊
AU762692C (en) Modified starch film compositions
US20070254024A1 (en) Process for manufacturing films
US6635275B1 (en) Modified starch film compositions
JP6190078B2 (ja) 部分的に中和されたエステル化セルロースエーテルを含む分散体
RU2012116362A (ru) Кислотоустойчивые капсулы
JP6254719B2 (ja) エステル化セルロースエーテルを含む分散体
TWI539976B (zh) 腸溶硬膠囊之組合物與使用此組合物所得之腸溶硬膠囊
JP6511174B1 (ja) 改善されたフィルム特性を有するプルラン硬質カプセルの製造方法
KR20250026264A (ko) 경질 셸 캡슐, 막 및 코팅을 위한 막 형성 지연형/장용 제형
JP7377782B2 (ja) フィルム成形用組成物及びフィルム
KR20120054388A (ko) 장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐
KR101815055B1 (ko) 장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐
TWI554290B (zh) 用於腸溶硬膠囊的組成物、使用該組成物製備的腸溶硬膠囊
PL239878B1 (pl) Wodna kompozycja oraz sposób wytwarzania dojelitowych elastycznych filmów do sporządzania kapsułek z wodnej kompozycji oraz dojelitowy elastyczny film do sporządzania kapsułek miękkich
CN106138007A (zh) 制备肠溶性胶囊壳的组成物、肠溶性胶囊壳及制备方法
JP2017501194A (ja) 硬質カプセル用水性組成物及びこれを使用して製造された硬質カプセル